Tap into a Global Network of Leading CNS Drug Developers, Forge Strategic Partnerships & Propel Your Business Forward
With the ALS and FTD R&D field facing a tumultuous few years of wins and clinical setbacks, the pharma and biotech community remain committed to the field, funding programs with strong biological rationale and long‑term potential. Fueled by significant strategic investment, including Eli Lilly’s $1B+ deployed across multiple ALS partnerships, Takeda’s ~$580M entry into ALS via AcuraStem, and BMS’s $2B+ collaboration with insitro to uncover genetically validated ALS targets, the ALS community continues to drive towards and cure.
Despite continued investment, research is hindered by bottlenecks spanning disease heterogeneity and model translation to biomarker development, trial execution, and regulatory risk. The 5th ALS Drug Development Summit brings together 100+ senior leaders, innovators, and scientists actively seeking an edge to advance
their research.
Are you looking to elevate your continued commitment to the ALS & FTD community and driving meaningful progress for patients?
What to Expect
Accelerate High‑Value Connections & Opportunities: Amplify your exposure to industry leaders through curated networking sessions and 1‑to‑1 meetings. Forge meaningful relationships that translate into new business opportunities across the ALS landscape.
Learn from the Latest Market Shifts: Stay informed on emerging trends, innovative therapies, and evolving clinical trial approaches. Gain insights that help you stay ahead of a rapidly changing ALS research and treatment environment.
Strengthen Your Product Position & Become a Partner of Choice: Showcase your unique capabilities and services to position your company as a strategic partner for ALS drug developers. Stand out among providers, imaging specialists, and CROs by demonstrating a strong track record in neurodegenerative disease research and collaboration.
Drug Developers are Actively Seeking:
In Vitro Models:
3D Cultures, hIPSCs and brain organoids to mimic complex and heterogenous ALS and FTD pathology
Clinical CROS
Offering trial design and program management with strong PI connections, reliability and efficiency
In Vivo Models:
Including TDP43, and C9orf72 rodent models to better predict efficacy in humans
Biomarker Discovery
Largescale biomarker discovery platforms for early ID of novel biomarkers through comprehensive proteomic profiling
Genomic & Proteomic Solutions
Including sequencing, genotyping and protein quantification
Diagnostic Tests
High sensitivity plasma and CSF assays for ALS for NFL and TDP43
Drug Discovery
High throughput AI & ML driven engines to support data-driven drug discovery for ALS
Recognize yourself and your business priorities in this description? With speaking and exhibitor inventory already running low, don’t hesitate to Reach Out for more information on partnership packages, attendee lists and create a bespoke package that aligns with your goals together.
Hear What Our Past Sponsors Have to Say
Great presentations and networking.
Senior Manager, Business Development, BrainXell
Great research and key opinion leader availability to discuss.
Director – Business Development, Elixirgen Scientific
The conference was very intimate which made it much easier to strike up conversations and interact with presenters.
Data Scientist, Unlearn AI
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Katie Orchard
Partnerships Director
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.